Literature DB >> 1718681

Optimum use of growth hormone in children.

Z Laron1, O Butenandt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1718681     DOI： 10.2165/00003495-199142010-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  67 in total

1.  Effect of recombinant human growth hormone therapy on bone and clinical parameters in girls with Turner's syndrome. The Spanish Collaborative Group.

Authors:  A Ferrández; E Mayayo; J M Arnal; C García; C Buñuel; J J Lasarte; R Anton; P Puyuelo
Journal:  Acta Paediatr Scand Suppl       Date:  1989

2.  Quality of life of adults with growth hormone deficiency: a controlled study.

Authors:  S Björk; B Jönsson; O Westphal; J E Levin
Journal:  Acta Paediatr Scand Suppl       Date:  1989

3.  Growth hormone treatment in adults with growth hormone deficiency: effect on muscle fibre size and proportions.

Authors:  H M Whitehead; J S Gilliland; I V Allen; D R Hadden
Journal:  Acta Paediatr Scand Suppl       Date:  1989

4.  Classic pages in obstetrics and gynecology by Henry H. Turner. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology, vol. 23, pp. 566-574, 1938.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  1972-05-15       Impact factor: 8.661

5.  Turner syndrome: spontaneous growth in 150 cases and review of the literature.

Authors:  M B Ranke; H Pflüger; W Rosendahl; P Stubbe; H Enders; J R Bierich; F Majewski
Journal:  Eur J Pediatr       Date:  1983-12       Impact factor: 3.183

6.  Purified human growth hormone from E. coli is biologically active.

Authors:  K C Olson; J Fenno; N Lin; R N Harkins; C Snider; W H Kohr; M J Ross; D Fodge; G Prender; N Stebbing
Journal:  Nature       Date:  1981-10-01       Impact factor: 49.962

7.  Control of misincorporation of de novo synthesized norleucine into recombinant interleukin-2 in E. coli.

Authors:  L B Tsai; H S Lu; W C Kenney; C C Curless; M L Klein; P H Lai; D M Fenton; B W Altrock; M B Mann
Journal:  Biochem Biophys Res Commun       Date:  1988-10-31       Impact factor: 3.575

8.  Plasma growth hormone concentration in corticosteroid-treated children.

Authors:  H G Morris; J R Jorgensen; S A Jenkins
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

9.  Growth hormone deficiency and growth hormone therapy in Ullrich-Turner-syndrome.

Authors:  O Butenandt
Journal:  Klin Wochenschr       Date:  1980-01-15

10.  Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon.

Authors:  N Mauras; R M Blizzard; K Link; M L Johnson; A D Rogol; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  1987-03       Impact factor: 5.958
View more
  2 in total

Review 1.  Growth hormone secretagogues. Clinical experience and therapeutic potential.

Authors:  Z Laron
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

2.  Efficacy and safety of a new ready-to-use recombinant human growth hormone solution.

Authors:  T Romer; F Peter; P Saenger; J Starzyk; B Koehler; E Korman; M Walczak; R Wasik; M Ginalska-Malinowska; E Solyom; A Berghout
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.